Trademark Search  /  ZELIS NSA CLAIM ADVANTAGE

ZELIS NSA CLAIM ADVANTAGE

● Live · Pending

U.S. federal trademark · Serial No. 99796095

Mark
ZELIS NSA CLAIM ADVANTAGE
Status
Pending
Serial Number
99796095
Filing Date
April 29, 2026
Class(es)
Class 042

Owner

ZELIS HEALTHCARE, LLC
16 · Boston, MA, US

Goods & Services

Software as a service (SAAS) services featuring software using artificial intelligence (AI) for managing the No Surprises Act dispute lifecycle between healthcare providers and payers, including claim pricing, automated eligibility validation, predictive outcome modeling, independent dispute resolution workflows, and defending financial outcomes through claim pricing analytics; Platform as a service (PAAS) featuring computer software platforms for managing the No Surprises Act dispute lifecycle between healthcare providers and payers, including claim pricing, automated eligibility validation, predictive outcome modeling, independent dispute resolution workflows, and defending financial outcomes through claim pricing analytics; Platform as a service (PAAS) featuring computer software platforms for optimizing healthcare No Surprises Act payment dispute performance, providing real-time case visibility, and utilizing predictive intelligence to inform negotiation strategies and manage arbitration volume relating to payment disputes between healthcare providers and payers; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for optimizing healthcare No Surprises Act payment dispute performance, providing real-time case visibility, and utilizing predictive intelligence to inform negotiation strategies and manage arbitration volume relating to payment disputes between healthcare providers and payers

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ZELIS NSA CLAIM ADVANTAGE" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.